4-(Hydroxymethyl)Pyrrolidin-3-Ol Hydrochloride
- $323 - $1027
- Product name: 4-(Hydroxymethyl)Pyrrolidin-3-Ol Hydrochloride
- CAS: 1609403-89-5
- MF: C5H12ClNO2
- MW: 153.61
- EINECS:
- MDL Number:MFCD28024801
- Synonyms:4-(Hydroxymethyl)Pyrrolidin-3-Ol Hydrochloride;4-(Hydroxymethyl)Pyrrolidin-3-Ol Hydrochloride(WX601555);4-(HYDROXYMETHYL)PYRROLIDIN-3-OL HCL;4-(hydroxymethyl)-3-pyrrolidinol hydrochloride
4 prices
Selected condition:
Brand
- Chemenu
- Crysdot
Package
- 1g
- 5g
- ManufacturerChemenu
- Product numberCM323350
- Product description4-(Hydroxymethyl)pyrrolidin-3-olhydrochloride 95%
- Packaging1g
- Price$323
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM323350
- Product description4-(Hydroxymethyl)pyrrolidin-3-olhydrochloride 95%
- Packaging5g
- Price$968
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11244367
- Product description4-(Hydroxymethyl)pyrrolidin-3-olhydrochloride 95+%
- Packaging1g
- Price$342
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11244367
- Product description4-(Hydroxymethyl)pyrrolidin-3-olhydrochloride 95+%
- Packaging5g
- Price$1027
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Chemenu | CM323350 | 4-(Hydroxymethyl)pyrrolidin-3-olhydrochloride 95% | 1g | $323 | 2021-12-16 | Buy |
Chemenu | CM323350 | 4-(Hydroxymethyl)pyrrolidin-3-olhydrochloride 95% | 5g | $968 | 2021-12-16 | Buy |
Crysdot | CD11244367 | 4-(Hydroxymethyl)pyrrolidin-3-olhydrochloride 95+% | 1g | $342 | 2021-12-16 | Buy |
Crysdot | CD11244367 | 4-(Hydroxymethyl)pyrrolidin-3-olhydrochloride 95+% | 5g | $1027 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|